All conditions
Medical condition
Metabolic Dysfunction-Associated Steatohepatitis
Also known as: MASH · NASH · Non-Alcoholic Steatohepatitis
MASH is progressive hepatic inflammation and fibrosis layered on metabolic-associated fatty liver. Drivers include insulin resistance, visceral adiposity, dyslipidemia, and inflammation.
Last reviewed
Overview
What you need to know
Provider-reviewed evaluation pairs ALT, AST, GGT, lipid panel, A1c, fasting insulin, and non-invasive fibrosis scoring. Optimization addresses upstream metabolic drivers; hepatology referral handles advanced fibrosis.
Knowledge graph
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.